SCHEMBL844739

SCHEMBL844739

Brc1cccc2[nH]c3c(ccc4cc[nH]c43)c12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM3 Q86V86 3/20 0.55
PIM1 P11309 1/20 0.55
PIM2 Q9P1W9 1/20 0.55
CDK4 P11802 7/20 0.47
CCND1 P24385 7/20 0.47
CCNE2 O96020 6/20 0.47
CCNE1 P24864 6/20 0.47
CDK2 P24941 6/20 0.47
AHR P35869 2/20 0.43
CA12 O43570 1/20 0.40
CA9 Q16790 1/20 0.40
PRKACA P17612 3/20 0.40
PRKACG P22612 3/20 0.40
PRKACB P22694 3/20 0.40
CAMK2B Q13554 2/20 0.40
CAMK2G Q13555 2/20 0.40
CAMK2D Q13557 2/20 0.40
CAMK2A Q9UQM7 2/20 0.40
CCNB2 O95067 1/20 0.40
CDK1 P06493 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL844649 0.79 PIM3 (0.54) PIM3PIM1CDK4CCND1CCNE2
SCHEMBL23264350 0.78 KIF11 (0.61) PIM3PIM1PIM2CDK4CCND1
SCHEMBL29355577 0.76 PARP1 (0.53) PIM3PIM1PIM2CDK4CCND1
SCHEMBL22443317 0.76 PARP1 (0.53) PIM3PIM1PIM2CDK4CCND1
SCHEMBL28770519 0.76 CCNE2 (0.55) PIM3PIM1PIM2CDK4CCND1
SCHEMBL29755102 0.76 CCNE2 (0.55) PIM3PIM1PIM2CDK4CCND1
SCHEMBL844551 0.75 KIF11 (0.61) PIM3PIM1PIM2CDK4CCND1
SCHEMBL28721397 0.75 PIM1 (0.54) PIM3PIM1PIM2CDK4CCND1
SCHEMBL29414462 0.75 PIM1 (0.54) PIM3PIM1PIM2CDK4CCND1
SCHEMBL15796869 0.73 PARP1 (0.52) PIM3PIM1CDK4CCND1CCNE2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US claimed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP claimed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US claimed
JP-2011526610-A 2011-10-13 JP claimed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP claimed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO claimed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
US-8481586-B2 Pyrrolo[2,3-a] carbazoles and use thereof as PIM kinase inhibitors CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2013-07-09 US disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
EP-2326649-B1 NOVEL PYRROLO[2,3-a]CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NAT RECH SCIENT (FR) 2012-03-28 EP disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors UNIVERSITE BLAISE PASCAL-CLERMONT-FERRAND II (FR) 2011-10-27 US disclosed
EP-2326649-A1 NOVEL PYRROLO Ý2,3-A¨CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS Centre National de la Recherche Scientifique (FR) 2011-06-01 EP disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed
WO-2010000978-A1 NOVEL PYRROLO [2,3-A] CARBAZOLES AND USE THEREOF AS PIM KINASE INHIBITORS CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2010-01-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110263669-A1 Novel Pyrrolo [2,3-A] Carbazoles and Use Thereof as PIM Kinase Inhibitors PIM3, PIM1, PIM2 PIM3 1/4885PIM1 2/4885PIM2 3/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.